key: cord-0900953-i64hmc7y
authors: Larsson, Susanna C.; Gill, Dipender
title: Genetic predisposition to allergic diseases is inversely associated with risk of COVID‐19
date: 2021-01-12
journal: Allergy
DOI: 10.1111/all.14728
sha: c81d7dcceb62ee32887053978ec0e253f71757a2
doc_id: 900953
cord_uid: i64hmc7y

nan

To the Editor,

The host immune response is integral to determining susceptibility to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and severity of consequent coronavirus disease 2019 (COVID-19). 1 Allergic diseases such as allergic rhinitis (hay fever), atopic dermatitis (eczema) and asthma tend to cluster together in individuals, partly because of shared genetic factors that navigate the immune system. 2 However, it is not yet known whether genetic predisposition to allergic disease also relates to COVID-19 susceptibility. Understanding this relationship may provide mechanistic insight towards uncovering preventative and therapeutic strategies for COVID-19. To this end, we performed a Mendelian randomization analysis investigating how genetic predictors of allergic disease relate to COVID-19 susceptibility.

As genetic instruments for the primary analysis, we considered 136 uncorrelated (r 2 < 0.02) single nucleotide polymorphisms associated with a broad allergic disease phenotype (presence of at least one allergic disease, including allergic rhinitis, atopic dermatitis and asthma) at p < 3 × 10 −8 in a meta-analysis of 13 genome-wide association studies with a total of 180 129 cases and 180 709 controls (without the three allergic diseases), all of European descent. 2 Information on allergic disease was self-reported. The number of cases with each allergic disease is shown in Table S1 . The association estimates were adjusted for age, sex and genetic principal components of ancestry. 2 In secondary analyses, we separately considered single nucleotide polymorphisms associated with each allergic disease (Appendix S1). We conducted two-sample summary-level Mendelian randomization analyses using the random-effects inverse-variance weighted method (primary analysis) and several statistical sensitivity analysis methods that make different assumptions. 4 Analyses were conducted in Stata/SE (version 14.2) and R (version 3.4.3) using summary-level data only. Ethical approval and participant consent had previously been obtained.

Genetic predisposition to any allergic disease was associated with reduced susceptibility to COVID-19 but not clearly with risk of being hospitalized with COVID-19 ( Figure 1 ). Similar results were observed in statistical sensitivity analyses, although with wider confidence intervals that were likely attributable to lower statistical power (Figure 1 ). The associations of each single nucleotide polymorphism with allergic disease and COVID-19 susceptibility are displayed in Figure S1 . Secondary analyses based on genetic variants associated with different allergic diseases did not reveal associations with any particular allergic disease specifically, although the magnitude of the inverse association was most pronounced for allergic rhinitis albeit with broad confidence intervals ( Figure S2 ).

Our results provide evidence to support that the genetic factors underlying predisposition to allergic disease are protective against COVID-19. The pathophysiological process underlying COVID-19

involves an exaggerated host immune response. 5 Previous work has highlighted genetic associations between obesity and smoking with both allergic disease and severe COVID-19, 2,6 supporting immune dysregulation as a common underlying mechanism. Further work is required to unravel the specific pathways linking susceptibility to allergic disease with risk of COVID-19, for the purpose of identifying opportunities for clinical intervention.

The authors thank the investigators of the COVID-19 Host Genetics Initiative for sharing summary-level data.

Dr. Gill is employed part-time by Novo Nordisk, outside the submit- ACE2 is not only a receptor for SARS-CoV-2 but also the main enzyme for catalyzing the conversion of angiotensin II into angiotensin (1-7) and exerts anti-inflammatory effects in cardiovascular diseases. 10 However, the relationship between asthma-related allergic inflammation and ACE2 enzymatic activity, but not its expression in the airway, has not been assessed in vivo.

To explore these associations, we used an HDM-induced asthma mouse model, which is T2 dominant asthma model. C57BL/6 J mice were intratracheally exposed or not to HDM (10-15 mice/group) at days 0, 7, and 14. Bronchoalveolar lavage fluid (BALF) and lung tissue samples were harvested at days 3, 10, and 17 to count eosinophils and measure Ace2 expression ( Figure 1A , Appendix S1).

The eosinophil counts in BALF samples increased from day 3 to 17 concomitantly with repeated HDM exposure in a stepwise

Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients

Shared genetic origin of asthma, hay fever and eczema elucidates allergic disease biology

Covid-19 Host Genetics Initiative. The COVID-19 Host Genetics Initiative, a global initiative to elucidate the role of host genetic factors in susceptibility and severity of the SARS-CoV-2 virus pandemic

Guidelines for performing Mendelian randomization investigations

Characterization of the inflammatory response to severe COVID-19 illness

Cardiometabolic traits, sepsis, and severe COVID-19: a Mendelian randomization investigation